BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 25265308)

  • 1. Combining the test of memory malingering trial 1 with behavioral responses improves the detection of effort test failure.
    Denning JH
    Appl Neuropsychol Adult; 2014; 21(4):269-77. PubMed ID: 25265308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficiency and accuracy of the Test of Memory Malingering trial 1, errors on the first 10 items of the test of memory malingering, and five embedded measures in predicting invalid test performance.
    Denning JH
    Arch Clin Neuropsychol; 2012 Jun; 27(4):417-32. PubMed ID: 22543569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When 10 is enough: Errors on the first 10 items of the Test of Memory Malingering (TOMMe10) and administration time predict freestanding performance validity tests (PVTs) and underperformance on memory measures.
    Denning JH
    Appl Neuropsychol Adult; 2021; 28(1):35-47. PubMed ID: 30950290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Test of memory malingering with children: The utility of Trial 1 and TOMMe10 as screeners of test validity.
    Loughan AR; Perna R; Le J
    Child Neuropsychol; 2016; 22(6):707-17. PubMed ID: 26031205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance on the Test of Memory Malingering is predicted by the number of errors on its first 10 items on an inpatient epilepsy monitoring unit.
    Grabyan JM; Collins RL; Alverson WA; Chen DK
    Clin Neuropsychol; 2018 Apr; 32(3):468-478. PubMed ID: 28826306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOMM Trial 1 as a performance validity indicator in a criminal forensic sample.
    Fazio RL; Denning JH; Denney RL
    Clin Neuropsychol; 2017 Jan; 31(1):251-267. PubMed ID: 27456971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing evaluation time while maintaining accuracy: Cross-validation of the Test of Memory Malingering (TOMM) Trial 1 and first 10-item errors as briefer performance validity tests.
    Kraemer LDR; Soble JR; Phillips JI; Webber TA; Fullen CT; Highsmith JM; Alverson WA; Critchfield EA
    Psychol Assess; 2020 May; 32(5):442-450. PubMed ID: 32027161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation and clinical validation of consistency indices on the test of memory malingering.
    Davis JJ; Wall JR; Whitney KA
    Arch Clin Neuropsychol; 2012 Nov; 27(7):706-15. PubMed ID: 22951670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting test of memory malingering and medical symptom validity test failure within a Veterans Affairs Medical Center: use of the Response Bias Scale and the Henry-Heilbronner Index.
    Whitney KA
    Arch Clin Neuropsychol; 2013 May; 28(3):222-35. PubMed ID: 23493404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity of the test of memory malingering and the Nonverbal Medical Symptom Validity Test: a replication study.
    Armistead-Jehle P; Gervais RO
    Appl Neuropsychol; 2011 Oct; 18(4):284-90. PubMed ID: 22074067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of the Rey 15-Item Test, recognition trial, and error scores for detecting noncredible neuropsychological performance in a mixed clinical sample of veterans.
    Bailey KC; Soble JR; O'Rourke JJF
    Clin Neuropsychol; 2018 Jan; 32(1):119-131. PubMed ID: 28555516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between the Test of Memory Malingering (TOMM) and the Nonverbal Medical Symptom Validity Test (NV-MSVT) in adults with disability claims.
    Green P
    Appl Neuropsychol; 2011 Jan; 18(1):18-26. PubMed ID: 21390896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TOMM1 discrepancy index (TDI): A new performance validity test (PVT) that differentiates between invalid cognitive testing and those diagnosed with dementia.
    Denning JH
    Appl Neuropsychol Adult; 2023; 30(1):83-90. PubMed ID: 33945362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hit rates of adequate performance based on the test of memory malingering (TOMM) Trial 1.
    Gavett BE; O'Bryant SE; Fisher JM; McCaffrey RJ
    Appl Neuropsychol; 2005; 12(1):1-4. PubMed ID: 15788216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is the Rey 15-Item Memory Test II (Rey II) a valid symptom validity test?: comparison with the TOMM.
    Whitney KA; Hook JN; Steiner AR; Shepard PH; Callaway S
    Appl Neuropsychol; 2008; 15(4):287-92. PubMed ID: 19023746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examining the Test Of Memory Malingering Trial 1 and Word Memory Test Immediate Recognition as screening tools for insufficient effort.
    Bauer L; O'Bryant SE; Lynch JK; McCaffrey RJ; Fisher JM
    Assessment; 2007 Sep; 14(3):215-22. PubMed ID: 17690378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embedded assessment of validity using the continuous visual memory test in patients with traumatic brain injury.
    Krishnan M; Donders J
    Arch Clin Neuropsychol; 2011 Apr; 26(3):176-83. PubMed ID: 21355004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Trial 1 of the Test of Memory Malingering (TOMM) as a screening measure of effort: suggested discontinuation rules.
    Hilsabeck RC; Gordon SN; Hietpas-Wilson T; Zartman AL
    Clin Neuropsychol; 2011 Oct; 25(7):1228-38. PubMed ID: 21846261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of Trial 1 of the Test of Memory Malingering (TOMM).
    O'Bryant SE; Gavett BE; McCaffrey RJ; O'Jile JR; Huerkamp JK; Smitherman TA; Humphreys JD
    Appl Neuropsychol; 2008; 15(2):113-6. PubMed ID: 18568603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluating the Medical Symptom Validity Test (MSVT) in a Sample of Veterans Between the Ages of 18 to 64.
    Reslan S; Axelrod BN
    Appl Neuropsychol Adult; 2017; 24(2):132-139. PubMed ID: 27045467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.